HomeMarkets Markets FDA Approves New First-Line Med for Pancreatic Cancer as Drug’s Initial Developer Dissolves By Ilene February 15, 2024 0 484 FacebookTwitterPinterestWhatsApp Ipsen’s Onivyde is now FDA approved as a first-line treatment for metastatic pancreatic cancer, triggering a milestone payment to Merrimack …This post was originally published on this site Share FacebookTwitterPinterestWhatsApp Subscribe Login Notify of new follow-up comments new replies to my comments Please login to comment 0 Comments Inline Feedbacks View all comments Stay Connected149,291FansLike396,312FollowersFollow2,670SubscribersSubscribe Latest Articles Markets Trump Made a Deal That Gives Him Nothing He Wanted Markets Wednesday Retracement – Trump and Iran Call “Time Out” on World War III Markets U.S. and Iran Reach Two-Week Ceasefire with “Coordinated” Hormuz Reopening Markets Trump’s Fundamental Misunderstanding in Iran Markets Shameful — ‘I Love Viktor’: Trump and Vance Cheer on Orban in Hungarian Race Markets Trump Looks Frantic Markets Sneak Attack Tuesday – Trump Bombs Kharg Island (again) – Oil Hits $115 (again) Market News Trump Is Putting America’s Weaknesses on Display Energy Hormuz closure threatens the global food supply – why grocery price hikes are coming Markets Trump’s Justice Department Dropped 23,000 Criminal Investigations in Shift to Immigration Markets Monday Market Mayhem – Trump Praises Allah, Extends Deadline (again) and Promises War Crimes Markets Iran’s Revolutionary Guard would fiercely resist a US ground invasion. History proves it Market News Trump Warns Iran on Easter: ‘Open the F-ckin’ Strait, You Crazy Bastards’ Markets Authoritarian Trump Threatens Democracy in the United States Load more